𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estradiol and cognition during androgen deprivation in men with prostate carcinoma

✍ Scribed by Richard J. Wassersug; Dolly Wadhwa

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
48 KB
Volume
104
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Osteoporosis in men with prostate carcin
Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy : Recommendations for diagnosis and therapies
✍ Terrence H. Diamond; Celestia S. Higano; Matthew R. Smith; Theresa A. Guise; Fre πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Androgen‐deprivation therapy (ADT) is prescribed with increasing frequency for men with prostate carcinoma. There is growing concern about the effects of such therapy on the skeleton. In the current review, the authors addressed the current research, diagnostic methods, a

Natural history of bone complications in
Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy
✍ Tracey L. Krupski; Matthew R. Smith; Won Chan Lee; Chris L. Pashos; Jane Brandma πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 1 views

## Background: As evidence accumulates in favor of androgen deprivation therapy (adt) in patients with recurrent or metastatic prostate carcinoma, concern has increased regarding bone loss associated with therapeutic hypogonadism. the current study described the natural history of bone complication

Androgen deprivation therapy increases c
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
✍ Christopher S. Saigal; John L. Gore; Tracey L. Krupski; Janet Hanley; Matthias S πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 146 KB

## Abstract ## BACKGROUND. The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply. Although cardiovascular disease is the most common reason for death among men with prostate cancer who do not die of the disease itself, data regarding the effec